|
| |
@adenrx.com Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Adenosine Therapeutics,LLC
Charlottesville. Virginia. 22905. United States of America. Tel: (434) 220.9400. Fax: (434) 971.6912. Email: sabbott@adenrx.com. WWW:. www.adenrx.com/ ...
http://www.bioportfolio.com/biocorporate/17874-Adenosine_The...
|
Adenosine Therapeutics, LLC Awarded Phase II SBIR Grant to Treat ...
SOURCE Adenosine Therapeutics, LLC. Link to this page: Link to this page. Back to Top back to top Related links: http://www.adenrx.com/ ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioPortfolio - Adenocard
Recent Search Terms used to find this page: Adenocard | adenosine therapeutics | Joel Linden CV Therapeutics | adenosine | @adenrx.com | Director adenrx.com ...
http://www.bioportfolio.com/search/Adenocard.html...
|
Adenosine Therapeutics Announces Investment by Novartis Option ...
For more information on Adenosine Therapeutics, please visit our web site at http://www.adenrx.com. About Novartis Option Fund The Novartis Option Fund is a
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
BioPortfolio - Biocorporate Search Nasdaq
... and development company that was co-founded in 1999 by University of Virginia (UVa) Professor, Joel Linden and... www.adenrx.com/ View full profile
...
http://www.bioportfolio.com/biocorporate/Nasdaq-companies.ht...
|
{1} Awards {2} Phase II SBIR Grant To Develop New Drug Eluting ...
For more information on Adenosine Therapeutics, visit our web site at http://www .adenrx.com/. Adenosine Therapeutics, LLC ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1833752...
|
Drugs in development for Parkinson's disease: An update
http://www.adenrx.com/pipe.html. 59. Neurocrine Biosciences Inc: Research program for 2005. Company. Web Site (2005). ...
http://www.biomedcentral.com/content/pdf/cd-643369.pdf...
|
Adenosine Therapeutics Announces Investment by Novartis Option ...
CONTACT: Robert Capon of Adenosine Therapeutics, LLC, +1-434-220-9400 ext.201. Web site: http://www.adenrx.com/http://www.venturefund.novartis.com/ ...
http://www.biospace.com/news_story.aspx?NewsEntityId=60314...
|
"SBIR STTR Effective 27-AUG-06","Phase Type","Fiscal Year","State ...
... ROBERT A","Antagonists of A2B Receptors Improve Insulin Sensitivity","","ROB @ADENRX.COM","310 FOURTH STREET NE","SUITE 201","","","N" "SBIR","Phase II" ...
http://silk.nih.gov/public/cbz2zoz.@www.sbirsttr.fy2005.csv...
|
"SBIR STTR Effective 09-NOV-08","Phase Type","Fiscal Year","State ...
... Sepsis","Sandra C Abbott","sabbott@adenrx.com","310 FOURTH STREET NE","SUITE 201","","Adenosine Therapeutics/UVA","Y" "STTR","Phase I","2006","VIRGINIA" ...
http://silk.nih.gov/public/cbz2zoz.@www.sbirsttr.fy2006.csv...
|
|
